Cover Image
Market Research Report
Product code 
1064619

Excessive Daytime Sleepiness (EDS) - Epidemiology Forecast - 2032

Published: Pre-Order | DelveInsight Business Research LLP | 102 Pages | Delivery time: 2-10 business days

Price

Back to Top
Excessive Daytime Sleepiness (EDS) - Epidemiology Forecast - 2032
Published: Pre-Order
DelveInsight Business Research LLP
Content info: 102 Pages
Delivery time: 2-10 business days
  • Description
  • Table of Contents
  • List of Tables

DelveInsight's Excessive Daytime Sleepiness - Epidemiology Forecast-2032' report delivers an in-depth understanding of the Excessive Daytime Sleepiness, historical and forecasted epidemiology as well as the Excessive Daytime Sleepiness trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.

Excessive Daytime Sleepiness Disease Understanding

Excessive Daytime Sleepiness is characterized by a difficulty to stay awake and alert during the major waking episodes of the day, with sleep occurring unintentionally or at inappropriate times of the wake period. Excessive Daytime Sleepiness is often associated with a wide range of illnesses, including metabolic, cardiovascular, neurological, and psychiatric diseases with voluntary behaviors reflecting poor sleep and sleep debt, leading to disability and increased risk of mortality. Excessive Daytime Sleepiness is also commonly associated with social and economic consequences, thus constituting a significant public health problem.

Sleep plays a vital role in consolidating memory, restoring the immune system, and other vital processes. As a result, a lack of quality sleep may result in a host of symptoms that may not immediately connect to the sleep.

Excessive Daytime Sleepiness Diagnosis

If an individual constantly feels drowsy during the day and tends to fall asleep at an awkward time and places that affect the productivity of the individual, then that individual needs to consult with a treating physician and discuss the situation. The physician will inquire about the sleeping habits of the patient. The physician will also inquire about any history of alcohol or drug use or abuse currently or in the past. The individual may also be referred to a psychologist for a counseling session if the individual has some stress or emotional problem in life, which could be interfering with sleep. The physician may also order tests to know about the exact cause of Excessive Daytime Sleepiness.

Sleep studies, such as the polysomnogram (PSG), the multiple sleep latency tests (MSLT), and the maintenance of wakefulness test (MWT), must be performed in a sleep laboratory, and although more labor-intensive, may also help evaluate diminished alertness and excessive sleepiness.

Continued in the report…..

Excessive Daytime Sleepiness Epidemiology Perspective by DelveInsight

Excessive Daytime Sleepiness - best described as an urge to sleep during daytime hours - is a common problem, occurring at least 3 days a week in ~4-20% of the population. It affects the quality of life, workplace performance, and has safety implications, i.e., when driving. Sleep disorders that cause Excessive Daytime Sleepiness remain underdiagnosed and are easy to miss in clinical practice.

"In the epidemiology model of Excessive Daytime Sleepiness, we have considered five indications for the estimation of Excessive Daytime Sleepiness pool, i.e., Parkinson's disease (PD), Narcolepsy, Obstructive Sleep Apnea (OSA), Idiopathic Hypersomnia (IH), and Bipolar Disorder."

Excessive Daytime Sleepiness Detailed Epidemiology Segmentation

  • Total diagnosed prevalent cases of Excessive Daytime Sleepiness in the 7MM was found to be 6,857,997 cases in 2021, which are expected to increase at a CAGR of 2.91% during study period (2019-2032).
  • In 2021, the diagnosed prevalent population of Excessive Daytime Sleepiness in the United States was observed to be 3,736,749 cases.
  • As per the DelveInsight's assessment, In EU5, the total diagnosed prevalent cases of Excessive Daytime Sleepiness was 2,047,802 cases, in 2021.
  • Among the European countries, Germany had the highest diagnosed prevalent population of Excessive Daytime Sleepiness (617,370 cases), followed by France which had a diagnosed prevalent population of 512,453 cases in 2021.
  • In EU-5, UK had the lowest diagnosed prevalent population of 282,307 cases in 2021.
  • In 2021 in the US, there were approximately 582,059 cases of Parkinson's disease, 2,059,508 cases of OSA, 41,671 cases of Narcolepsy, 34,505 cases of IH, and 1,019,006 cases of Bipolar Disorder.
  • As per the DelveInsight analysis, it was observed that Japan accounted for approximately 16% diagnosed prevalent population of Excessive Daytime Sleepiness, among 7MM, in the year 2021.

Scope of the Report:

  • The report covers the descriptive overview of Excessive Daytime Sleepiness, explaining its signs and symptoms, causes, and classification.
  • Comprehensive insight has been provided into the Excessive Daytime Sleepiness epidemiology.
  • The report provides insight into the 7MM historical and forecasted patient population covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
  • The report assesses the disease risk and burden of Excessive Daytime Sleepiness.
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population.
  • The report provides the segmentation of the disease epidemiology for 7MM, total diagnosed prevalent cases of excessive daytime sleepiness and total diagnosed prevalent cases of excessive daytime sleepiness in different disorders.

Report Highlights:

  • 11-Year Forecast of Excessive Daytime Sleepiness
  • 7MM Coverage
  • Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness
  • Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Different Disorders

Key Questions Answered

  • What is the unmet needs of Excessive Daytime Sleepiness?
  • What is the historical Excessive Daytime Sleepiness patient population in the United States, EU5 (Germany, France, Italy, Spain, and the UK) and Japan?
  • What would be the forecasted patient population of Excessive Daytime Sleepiness at the 7MM level?
  • What will be the growth opportunities across the 7MM with respect to the patient population pertaining to Excessive Daytime Sleepiness?
  • Out of the above-mentioned countries, which country would have the highest prevalent population of Excessive Daytime Sleepiness during the forecast period (2022-2032)?
  • At what CAGR the population is expected to grow across the 7MM during the forecast period (2022-2032)?

Reasons to buy:

The Excessive Daytime Sleepiness report will allow the user to -

  • Develop business strategies by understanding the trends shaping and driving the 7MM Excessive Daytime Sleepiness epidemiology forecast.
  • The Excessive Daytime Sleepiness epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists.
  • The Excessive Daytime Sleepiness epidemiology model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over the 11-year forecast period using reputable sources.

Key Assessments

  • Patient Segmentation
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2019-2032

Product Code: DIEI0585

Table of Contents

1 Key Insights

2 Report Introduction

3 Excessive Daytime Sleepiness Epidemiology Overview at a Glance

  • 3.1 Patient Share (%) Distribution of Excessive Daytime Sleepiness in 2019
  • 3.2 Patient Share (%) Distribution of Excessive Daytime Sleepiness in 2032

4 Executive Summary of Excessive Daytime Sleepiness

5 Excessive Daytime Sleepiness: Disease Background and Overview

  • 5.1. Introduction
  • 5.2. Causes of Excessive Daytime Sleepiness
  • 5.3. Symptoms of Excessive Daytime Sleepiness
  • 5.4. Classification
  • 5.5. Diagnosis
    • 5.5.1. Diagnostic Algorithm
    • 5.5.2. Diagnosis Guidelines

6 Epidemiology and Patient Population

  • 6.1. Key Findings
  • 6.2. Epidemiology Methodology
  • 6.3. Assumptions and Rationale: 7MM
    • 6.3.1. The United States
    • 6.3.2. Five Major European Countries (Germany, France, Italy, Spain, and the United Kingdom)
      • 6.3.2.1. Germany
      • 6.3.2.2. France
      • 6.3.2.3. Italy
      • 6.3.2.4. Spain
      • 6.3.2.5. The United Kingdom
    • 6.3.3. Japan
  • 6.4. Total Diagnosed Prevalent Population of Excessive Daytime Sleepiness in the 7MM
  • 6.5. The United States
    • 6.5.1. Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in the United States
    • 6.5.2. Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Different Disorders in the United States
  • 6.6. Five Major European Countries (Germany, France, Italy, Spain, and the United Kingdom)
    • 6.6.1. Germany
      • 6.6.1.1. Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Germany
      • 6.6.1.2. Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Different Disorders in Germany
    • 6.6.2. France
      • 6.6.2.1. Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in France
      • 6.6.2.2. Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Different Disorders in France
    • 6.6.3. Italy
      • 6.6.3.1. Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Italy
      • 6.6.3.2. Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Different Disorders in Italy
    • 6.6.4. Spain
      • 6.6.4.1. Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Spain
      • 6.6.4.2. Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Different Disorders in Spain
    • 6.6.5. The United Kingdom
      • 6.6.5.1. Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in the UK
      • 6.6.5.2. Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Different Disorders in the UK
  • 6.7. Japan
    • 6.7.1. Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Japan
    • 6.7.2. Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Different Disorders in Japan

7 Patient Journey

8 KOL Views

  • 8.1. United States
  • 8.2. EU-5
  • 8.3. Japan

9 Appendix

  • 9.1. Bibliography
  • 9.2. Report Methodology

10 DelveInsight Capabilities

11 Disclaimer

12 About DelveInsight

List of Tables

  • Table 1 Summary of Excessive Daytime Sleepiness Epidemiology (2019-2032)
  • Table 2 Common Causes or Contributors to Excessive Daytime Sleepiness
  • Table 3 ESS Scores
  • Table 4 Diagnostic Criteria for Narcolepsy Types 1 and 2 (Adapted from ICSD-3)
  • Table 5 Diagnostic Criteria for Idiopathic Hypersomnia (adapted from ICSD-3)
  • Table 6 Current Pharmacologic Treatment of Excessive Daytime Sleepiness Associated with Narcolepsy
  • Table 7 American Academy of Sleep Medicine Clinical Practice Guideline for the Treatment of Central Disorders of Hypersomnolence (1/3)
  • Table 8 American Academy of Sleep Medicine Clinical Practice Guideline for the Treatment of Central Disorders of Hypersomnolence (2/3)
  • Table 9 American Academy of Sleep Medicine Clinical Practice Guideline for the Treatment of Central Disorders of Hypersomnolence (3/3)
  • Table 10 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in the 7MM, in '000' (2019-2032)
  • Table 11 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in the US, in '000' (2019-2032)
  • Table 12 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Different Disorders in the US, in '000' (2019-2032)
  • Table 13 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in EU-5, in '000' (2019-2032)
  • Table 14 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Different Disorders in EU-5, in '000' (2019-2032)
  • Table 15 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Germany, in '000' (2019-2032)
  • Table 16 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Different Disorders in Germany, in '000' (2019-2032)
  • Table 17 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in France, in '000' (2019-2032)
  • Table 18 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Different Disorders in France, in '000' (2019-2032)
  • Table 19 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Italy, in '000' (2019-2032)
  • Table 20 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Different Disorders in Italy, in '000' (2019-2032)
  • Table 21 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Spain, in '000' (2019-2032)
  • Table 22 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Different Disorders in Spain, in '000' (2019-2032)
  • Table 23 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in the UK, in '000' (2019-2032)
  • Table 24 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Different Disorders in the UK, in '000' (2019-2032)
  • Table 25 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Japan, in '000' (2019-2032)
  • Table 26 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Different Disorders in the Japan, in '000' (2019-2032)

List of Figures

  • Figure 1 How EDS is Different from Fatigue?
  • Figure 2 Causes of Excessive Daytime Sleepiness
  • Figure 3 Symptoms of Excessive Daytime Sleepiness
  • Figure 4 Suggested Clinical Algorithm for the Diagnosis of Suspected OSA, Narcolepsy, or Other Sleep Disorders Based on Symptoms of Excessive Daytime Sleepiness
  • Figure 5 Clinical Approach in the Diagnosis of Excessive Daytime Sleepiness
  • Figure 6 Diagnostic and Treatment Approach for Excessive Daytime Sleepiness
  • Figure 7 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in the 7MM, in '000' (2019-2032)
  • Figure 8 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Different Disorders in the 7MM, in '000' (2019-2032)
  • Figure 9 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in the US, in '000' (2019-2032)
  • Figure 10 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Different Disorders in the US, in '000' (2019-2032)
  • Figure 11 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in EU-5, in '000' (2019-2032)
  • Figure 12 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Different Disorders in EU-5, in '000' (2019-2032)
  • Figure 13 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Germany, in '000' (2019-2032)
  • Figure 14 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Different Disorders in Germany, in '000' (2019-2032)
  • Figure 15 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in France, in '000' (2019-2032)
  • Figure 16 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Different Disorders in France, in '000' (2019-2032)
  • Figure 17 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Italy, in '000' (2019-2032)
  • Figure 18 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Different Disorders in Italy, in '000' (2019-2032)
  • Figure 19 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Spain, in '000' (2019-2032)
  • Figure 20 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Different Disorders in Spain, in '000' (2019-2032)
  • Figure 21 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in the UK, in '000' (2019-2032)
  • Figure 22 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Different Disorders in the UK, in '000' (2019-2032)
  • Figure 23 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Japan, in '000' (2019-2032)
  • Figure 24 Total Diagnosed Prevalent Cases of Excessive Daytime Sleepiness in Different Disorders in the Japan, in '000' (2019-2032)